First report of simultaneous assessment of hepatitis A virus and hepatitis E virus seroprevalence among soldiers in Iran

Khodayar Ghorban, Maryam Dadmanesh, Hasan Mohammadnezhad, Hamed Naziri


Hepatitis E virus (HEV) and Hepatitis A virus (HAV) have been considered as common causes of viral hepatitis to military service members since their discovery. Although Iran has been recognized as an endemic country for HAV and HEV there is no study about HAV and HEV simultaneous prevalence among Iranian soldiers. The purpose of this study was to assess anti-HAV and anti-HEV antibodies in Iranian soldiers concurrently. In this cross-sectional study, a total of 400 serum samples were collected by simple random sampling for detection of anti-HAV and anti-HEV IgG by commercial HEV enzyme-linked immunosorbent assay (ELISA) kit. Out of 400 individuals, all participants were male with ages ranging from 18 to 26 years. Totally, 12% and 0.5% of the tested specimens were positive for anti-HAV and anti-HEV respectively. There were no significant differences between the subjects grouped according to age groups. Our finding presented a dramatic decrease in seropositivity against HAV. Therefore, vaccination for HAV should be reevaluated for military services in Iran.


HAV, HEV, Soldiers, Iran

Full Text:

Full-text PDF


Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008; 48(3):494-503.

Naziri H, Tahamtan A, Moradi A, Tabarraei A. Evaluation of anti-hepatitis E virus antibody among hemodialysis patients in Gorgan, north of Iran. Iran J Virol. 2016; 10(2):13-8.

Dadmanesh M, Hosseinzadeh M, Keyvani H, Ghorban K, Rahimi M, Hosseinzadeh M, et al. Evaluation of prevalence and risk factors of hepatitis g virus infection among hemodialysis patients referred to Iranian army hospitals in tehran during 2012-2013. Hepat Mon. 2015; 15(1):e18322.

Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, et al. GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study. Hepat Mon. 2013; 13(12):e15342.

Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995; 171(2):447-50.

Karimi A, Imani-Rastabi R, Moezzi M, Moradi M. Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran. Arch Clin Infect Dis. 2016; 11(1):e32288.

Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol. 2016; 22(22):5143-53.

Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015; 8(7):e19311.

Vitral CL, da Silva-Nunes M, Pinto MA, de Oliveira JM, Gaspar AM, Pereira RC, et al. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia. BMC Infect Dis. 2014; 14:458.

Cuevas-Ferrando E, Randazzo W, Pérez-Cataluña A, Sánchez G. HEV Occurrence in Waste and Drinking Water Treatment Plants. Front Microbiol. 2019; 10:2937.

Ghorbani GA, Alavian S-M, Esfahani AA, Assari S. Seroepidemiology of hepatitis E virus in Iranian soldiers. Hepat Mon. 2007; 7(3):123-6.

Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005; 34(3):600-9.

Nagashima S, Ko K, Yamamoto C, Bunthen E, Ouoba S, Chuon C, et al. Prevalence of total hepatitis A antibody among 5 to 7 years old children and their mothers in Cambodia. Sci Rep. 2021; 11(1):4778.

Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006; 28:101-11.

Mardani M. Is Hepatitis E a Vaccine Preventable Diseases? Arch Clin Infect Dis. 2015; 10(2):e28726.

Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014; 27(1):116-38.

Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012; 106(9):528-31.

Smith SK, Rosenthal P. Hepatitis A and Hepatitis E Virus in Children. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver Disease in Children. 5 ed. Cambridge: Cambridge University Press; 2021. p. 273-84.

Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016; 9(2):100-4.

Ghorbani GA, Alavian S-M, Asaari S. Seroepidemiology of hepatitis A virus in Iranian soldiers in 2006: do they need vaccination? Hepat Mon. 2007; 7(1):7-9.

Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016; 16(1):e32215.



  • There are currently no refbacks.

Copyright (c) 2022 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.